Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor

Helen C. Su(Ontario Institute for Cancer Research), Nicolas Bidère(Ontario Institute for Cancer Research), Lixin Zheng(Ontario Institute for Cancer Research), Alan Cubre(Ontario Institute for Cancer Research), Keiko Sakai(Ontario Institute for Cancer Research), Janet K. Dale(Ontario Institute for Cancer Research), Leonardo Salmena(Ontario Institute for Cancer Research), Razqallah Hakem(Ontario Institute for Cancer Research), Stephen E. Straus(Ontario Institute for Cancer Research), Michael J. Lenardo(Ontario Institute for Cancer Research)
Science
March 3, 2005
Cited by 422

Abstract

Caspase-8, a proapoptotic protease, has an essential role in lymphocyte activation and protective immunity. We show that caspase-8 deficiency (CED) in humans and mice specifically abolishes activation of the transcription factor nuclear factor kappaB (NF-kappaB) after stimulation through antigen receptors, Fc receptors, or Toll-like receptor 4 in T, B, and natural killer cells. Caspase-8 also causes the alphabeta complex of the inhibitor of NF-kappaB kinase (IKK) to associate with the upstream Bcl10-MALT1 (mucosa-associated lymphatic tissue) adapter complex. Recruitment of the IKKalpha, beta complex, its activation, and the nuclear translocation of NF-kappaB require enzyme activity of full-length caspase-8. These findings thus explain the paradoxical association of defective apoptosis and combined immunodeficiency in human CED.


Related Papers